Alternatives for potentially inappropriate medications in the elderly population: Treatment algorithms for use in the Fleetwood Phase III study

Consultant Pharmacist

Volumn 19, Issue 11, 2004, Pages 1011-1028

  Christian, Jennifer B ^a   VanHaaren, Anne ^b   Cameron, Kathleen A ^c   Lapane, Kate L ^a  

^a BROWN UNIVERSITY   (United States)

^b Coastal Medical Inc ^*  (United States)

^c ASCP Res and Education Foundation   (United States)

Author keywords

Adverse drug events; Fleetwood Phase III study; Geriatrics; Inappropriate medications; Nursing homes

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BELLADONNA ALKALOID; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CHLORPROPAMIDE; CLIDINIUM; DICYCLOVERINE; DIGOXIN; DIHYDROERGOTOXINE MESILATE; DIPHENHYDRAMINE; DIPYRIDAMOLE; DISOPYRAMIDE; DOLASETRON MESILATE; DOXEPIN; GRANISETRON; HYOSCYAMINE; INDOMETACIN; LONG ACTING DRUG; MEPROBAMATE; METHYLDOPA; MUSCLE RELAXANT AGENT; ONDANSETRON; PENTAZOCINE; PETHIDINE; PHENYLBUTAZONE; PROPANTHELINE BROMIDE; RESERPINE; SPASMOLYTIC AGENT; TICLOPIDINE; TRIMETHOBENZAMIDE; UNINDEXED DRUG;

ALGORITHM; ALLERGY; BRADYCARDIA; COMPUTER PROGRAM; CONFUSION; CONSENSUS; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIARRHEA; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG UTILIZATION; EUPHORIA; EVALUATION; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; GERIATRIC CARE; HALLUCINATION; HEALTH CARE FACILITY; HEART ARRHYTHMIA; HUMAN; HYPOGLYCEMIA; IMPOTENCE; LONG TERM CARE; MEDICARE; MEDICATION ERROR; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; NURSING HOME; ORTHOSTATIC HYPOTENSION; PHARMACIST; PHARMACY; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; QT PROLONGATION; RETROGRADE AMNESIA; REVIEW; SEDATION; SIDE EFFECT; STANDARDIZATION; UNITED STATES; VOMITING;

EID: 8544262916     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2004.1011     Document Type: Review

References (44)

1. Baum C, Kennedy D, Knapp D. Drug utilization in the United States: 1986. Rockville, MD: Department of Health and Human Services, Food and Drug Administration; 1987.
2. Bernabei R, Gambassi G, Lapane K et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. SAGE (Systematic Assessment of Geriatric drug use via Epidemiology) Study Group. J Gerontol A Biol Sci Med Sci 1999;54:M25-M33.
3. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990;38:542-52.
4. Beers MH, Ouslander JG, Rollingher I et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151:1825-32.
5. Schmader KE, Hanlon JT, Landsman PB et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997;31:529-33.
6. Gurwitz JH, Field TS, Avorn J et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:87-94.
7. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997;157:2089-96.
8. Rhoades J. Nursing homes: structure and selected characteristics, 1987 and 1996. In: Metropolitan Insurance Companies. New York, NY: 1998.
9. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997;157:1531-6.
10. Williams B, Betley C. Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc 1995;43:513-9.
11. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992;117:684-9.
12. Dhalla IA, Anderson GM, Mamdani MM et al. Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 2002;50:995-1000.
13. Dhall J, Larrat EP, Lapane KL. Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 2002;22:88-96.
14. Nursing Home Survey Procedures and Interpretive Guidelines, TAG F329 Guidelines 483.25(1)(1):114. Baltimore, Maryland; Centers for Medicare & Medicaid Services; 1999.
15. Nursing Home Survey Procedures and Interpretive Guidelines, TAG F428 Guidelines 483.60(c)(1):163. Baltimore, MD: Centers for Medicare and Medicaid Services; 1999.
16. Nursing Home Survey Procedures and Interpretive Guidelines, TAG F429 Guidelines 483.60(c)(2):164. Baltimore, MD: Centers for Medicare & Medicaid Services; 1999.
17. Daschner M, Brownstein S, Cameron K et al. Fleetwood phase II tests a new model of long term care pharmacy. Consult Pharm 2000;15:989-1005.
18. Cameron K, Feinberg J, Lapane K. Fleetwood project phase III moves forward. Consult Pharm 2002;17:181-98.
19. Lapane K, Hughes C. Identifying nursing home residents at high-risk for preventable adverse drug events: modifying a tool for use in the Fleetwood phase III study. Consult Pharm 2004;19:533-7.
20. McLeod PJ, Huang AR, Tamblyn RM et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997;156:385-91.
21. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
22. Albers GW, Amarenco F, Easton JD et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001;119:s300-s320.
23. Semla T, Beizer I, Higbee M. Geriatric Dosage Handbook. 6th ed. Hudson, Cleveland, OH: Lexi-Comp, Inc.; 2001.
24. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Pract Res Clin Gastroenterol 2002;16:63-76.
25. Cavalieri TA. Pain management in the elderly. J Am Osteopath Assoc 2002;102:481-5.
26. The management of chronic pain in older persons: AGS panel on chronic pain in older persons. J Am Geriatr Soc 1998;46:635-51.
27. Feinberg SD. Prescribing analgesics. How to improve function and avoid toxicity when treating chronic pain. Geriatrics 2000;55:44, 49-50, 53.
28. Thorpe L, Whitney DK, Kutcher SP et al. Clinical guidelines for the treatment of depressive disorders. VI. Special populations. Can J Psychiatry 2001;46(suppl 1):s63-s76.
29. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018-24.
30. Herings RM, Stricker BH, de Boer A et al. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995;155:1801-7.
31. Sgadari A, Lapane KL, Mor V et al. Oxidative and nonoxidative benzodiazepines and the risk of femur fracture. The Systematic Assessment of Geriatric Drug Use Via Epidemiology Study Group. J Clin Psychopharmacol 2000;20:234-9.
32. Adams KF Jr, Gheorghiade M, Uretsky BF et al. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002;39:946-53.
33. Miura T, Kojima R, Sugiura Y et al. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000;34:427-32.
34. Short RI, Ray WA, Daugherty JR et al. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996;44:751-5.
35. Gurwitz J. Using pharmacoepidemiological findings to guide clinical practice: sulfonylureas and hypoglycemica in older adults. JAGS 1996;44.
36. Holstein A, Plaschke A, Egberts EH. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 2001;17:467-73.
37. Kaliner MA. H1-antihistamines in the elderly. Clin Allergy Immunol 2002;17:465-81.
38. Goodin S, Cunningham R. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist 2002;7:424-36.
39. Barnes MP. Spasticity: a rehabilitation challenge in the elderly. Gerontology 2001;47:295-9.
40. Fick D, Cooper I, Wade W. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a U.S. Consensus Panel of Experts. Arch Intern Med 2003;163:2716-24.
41. Beers MH, Fingold SF, Ouslander JG. A computerized system for identifying and informing physicians about problematic drug use in nursing homes. J Med Syst 1992;16:237-45.
42. Gupta S, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clin Ther 1996;18:183-96.
43. Gill S, Misiaszek B, Brymer C. Improving prescribing in the elderly: a study in the long term care setting. Can J Clin Pharmacol 2001;8:78-83.
44. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.